Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven S Good

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Antimicrobial Agents and Chemotherapy|July 18, 2002
Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of actionKaren K Biron, Robert J Harvey, Stanley C Chamberlain, et al.
Nature Communications|February 3, 2022
A dual mechanism of action of AT-527 against SARS-CoV-2 polymeraseAshleigh Shannon, Véronique Fattorini, Bhawna Sama, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Antimicrobial Agents and Chemotherapy|July 18, 2002
Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of actionKaren K Biron, Robert J Harvey, Stanley C Chamberlain, et al.
Nature Communications|February 3, 2022
A dual mechanism of action of AT-527 against SARS-CoV-2 polymeraseAshleigh Shannon, Véronique Fattorini, Bhawna Sama, et al.
Pageof 2